No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy

Affiliations

¹ Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Istituto Pasteur Italia, Rome 00185, Italy. Electronic address: carolina.scagnolari@uniroma1.it.
² Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Istituto Pasteur Italia, Rome 00185, Italy.
³ Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
⁴ Department of Maternal Science, Sapienza University of Rome, Rome 00185, Italy.
⁵ Lazio Reference Center for Cystic Fibrosis, Policlinico Umberto I University Hospital, Rome 00185, Italy.
⁶ Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Istituto Pasteur Italia, Rome 00185, Italy; Microbiology and Virology Unit, Hospital "Policlinico Umberto I", Sapienza University, Rome 00185, Italy.

Comment

Carolina Scagnolari et al. J Cyst Fibros. 2020 Sep.

. 2020 Sep;19(5):837-838.

doi: 10.1016/j.jcf.2020.06.018. Epub 2020 Jun 23.

¹ Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Istituto Pasteur Italia, Rome 00185, Italy. Electronic address: carolina.scagnolari@uniroma1.it.
² Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Istituto Pasteur Italia, Rome 00185, Italy.
³ Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
⁴ Department of Maternal Science, Sapienza University of Rome, Rome 00185, Italy.
⁵ Lazio Reference Center for Cystic Fibrosis, Policlinico Umberto I University Hospital, Rome 00185, Italy.
⁶ Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Istituto Pasteur Italia, Rome 00185, Italy; Microbiology and Virology Unit, Hospital "Policlinico Umberto I", Sapienza University, Rome 00185, Italy.

No abstract available

Keywords: Cystic fibrosis; Influenza virus; Respiratory infection; SARS-CoV-2.

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no conflicts of interests.

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML, Mulders DG, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MP, Drosten C. Corman VM, et al. Euro Surveill. 2020 Jan;25(3):2000045. doi: 10.2807/1560-7917.ES.2020.25.3.2000045. Euro Surveill. 2020. PMID: 31992387 Free PMC article.

1. Cosgriff R., Ahern S., Bell S.C., et al. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis. J Cyst Fibros. 2020 doi: 10.1016/j.jcf.2020.04.012. press. - DOI - PMC - PubMed
1. Poli P., Timpano S., Goffredo M., et al. Asymptomatic case of Covid-19 in an infant with cystic fibrosis. J Cyst Fibros. 2020 doi: 10.1016/j.jcf.2020.03.017. press. - DOI - PMC - PubMed
1. Corman V.M., Landt O., Kaiser M., et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25 - PMC - PubMed
1. Colombo C., Burgel P.R., Gartner S., et al. Impact of COVID-19 on people with cystic fibrosis. Lancet Respir Med. 2020;8:e35–e36. doi: 10.1016/S2213-2600(20)30177-6. - DOI - PMC - PubMed